Related Articles
Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation
Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
Adipose tissue-derived stem cells promote the reversion of non-alcoholic fatty liver disease: An in vivo study
SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells
Chinese herb extract improves liver steatosis by promoting the expression of high molecular weight adiponectin in NAFLD rats